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Genomic 
characterisation of 
human monkeypox 
virus in Nigeria
Monkeypox virus (MPXV) is a large, 
double-stranded DNA virus belonging 
to the Orthopox genus in the family 
Poxviridae. First identified in 1958, 
MPXV has caused sporadic human 
outbreaks in central and west Africa, 
with a mortality rate between 1% 
and 10%.1 Viral genomes from west 
Africa and the Congo Basin separate 
into two clades, the latter being more 
virulent.2 Recently, MPXV outbreaks 
have occurred in Sudan (2005), the 
Republic of the Congo and Democratic 
Republic of the Congo (2009), and the 
Central African Republic (2016).3
A suspected outbreak of human 
MPXV was reported to WHO on 
Sept 26, 2017, by the Nigeria Centre 
for Disease Control (NCDC) after a 
cluster of suspected cases had occurred 
in Yenagoa Local Government Area, 
Bayelsa State, Nigeria.4 Since the 
onset of the outbreak, 155 cases have 
been reported by the NCDC, of which 
56 were confirmed.4 A subset of 
these samples was sent to the WHO 
Collaborating Center at the Institut 
Pasteur de Dakar (IPD) in Senegal for 
confirmation by PCR.
This was not the first report of 
MPXV cases in Nigeria. Between 
1971 and 1978, ten human cases were 
reported, with three confirmed and 
two sequenced. Since then, no other 
cases have been reported in the area. 
Because of the lapse in MPXV cases 
in the region and recent cases in the 
Congo Basin, the origin of the Nigerian 
outbreak needed to be identified, as 
did whether the outbreak was a result 
of a local zoonotic spillover event or 
importation from another endemic 
country.
To help support advanced 
characterisation of pathogens in 
the region, 29 samples positive 
according to PCR were prepared 
for sequencing at IPD and enriched 
using a pan-viral probe set designed 
by Illumina (San Diego, CA, USA) 
and the US Army Medical Research 
Institute of Infectious Diseases Center 
for Genomic Sciences (Frederick, 
MD, USA), and synthesised by Twist 
Bioscience (San Francisco, CA, USA). 
Analysis of the sequencing data 
found reads aligning to MPXV in 
22 of the 29 samples. Three of the 
samples (297 957, 298 464, and 
298 481) were determined to have 
reads covering 99·8%, 94·2%, and 
95·0% of the closest related MPXV 
genome sequence on GenBank 
(a Nigeria strain, KJ642617) with 
average depths of 512, 56, and 25 × , 
respectively. Reads aligned to the 
repetitive terminal ends but could 
not be used to definitely resolve the 
termini using the short Illumina reads.
Phylogenetic analysis (appendix) 
indicates that the closest relative of the 
three outbreak isolates were the two 
Nigerian strains available on GenBank 
(KJ642615 and KJ642617), within 
the west African clade. The isolates 
grouped most closely to KJ642617, a 
genome isolated from a human MPXV 
case in Ihie, Abia State, Nigeria, in 
1971, which is relatively close to the 
epicentre of the current outbreak.
These findings support the 
hypothesis that the index case of the 
current outbreak in Nigeria was not 
imported, but probably originated 
from a spillover event or events 
involving reservoir hosts. These 
results emphasise the value of local 
surveillance for the early detection 
of viral spillovers and the need for 
advanced characterisation to help 
determine the origins of outbreaks.
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Beyond one virus: 
vaccination against 
hepatitis B after 
hepatitis C treatment
New treatments for hepatitis C virus 
(HCV) infection with direct-acting 
antivirals provide an extraordinary 
cure rate. A recent Article by 
